Latest Vertex Pharmaceuticals News & Updates

See the latest news and media coverage for Vertex. We track all announcements, press releases, and industry mentions in real time, all in one place.

Vertex Pharmaceuticals (Vertex)

Biopharmaceutical company

vrtx.com

Headquarters: Boston, United States
Founded year: 1989
Company type: Public company
Number of employees: 6,000–10,000

Last updated Today

Latest news about Vertex Pharmaceuticals (Vertex)

In short: Vertex reported strong 2025 revenue of $12 billion and advanced its pipeline with key FDA filings for kidney disease and pain management therapies.

Company announcements

June 11 Vertex

Vertex presents new CASGEVY data in children 5–11

Data from pivotal studies show transformative potential consistent with older patients; regulatory submissions made in US, Saudi Arabia, and UK.

June 1 Vertex

Vertex announces US FDA acceptance of BLA for povetacicept

The FDA set a PDUFA date of November 30, 2026, for accelerated approval in IgA nephropathy.

May 6 Vertex

Vertex announces CASGEVY reimbursement agreement in Germany

The deal with GKV-Spitzenverband ensures access for patients 12+ with sickle cell disease or transfusion-dependent beta thalassemia.

May 4 Vertex

Vertex reports Q1 2026 financial results

Total revenue reaches $2.99 billion, up 8% from 2025. Reiterates full-year guidance of $12.95-13.1 billion. Pipeline advances include povetacicept BLA submission.

Media coverage

Yesterday Yahoo Finance

Positive Pediatric CASGEVY Data Might Change The Case For Investing In Vertex Pharmaceuticals (VRTX)

Vertex Pharmaceuticals recently reported Phase 3 data showing that its CRISPR-based therapy CASGEVY delivered strong clinical benefits and a consistent safety profile in children ages...

June 22 The New York Times

A Loophole Brings Cystic Fibrosis Patients a ‘Miracle Drug’ in Generic Form

Josua Lottering stepped out the airport doors in the Bangladesh capital, Dhaka, and doubled over in...

June 20 Yahoo Finance

Vertex Has a Head Start in Non-Opioid Pain. Eli Lilly Just Spent Billions to Catch Up. Here s What That Means for Both...

Vertex Pharmaceuticals (NASDAQ: VRTX) and Eli Lilly (NYSE: LLY) are two leading drugmakers that...

June 18 AD HOC NEWS

Vertex Pharma Stock - Analyst consensus and technical picture on Nasdaq

Vertex Pharma stock trades near record territory on Nasdaq while analysts remain broadly positive on the biotech group's earnings outlook. A look at current ratings...

Never miss news about Vertex

Track Vertex and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Vertex competitors & trending companies

Browse news for competitors to Vertex and other trending companies.